Global Biologic Therapeutics Drugs Market Growth 2025-2031

October 2025 | 89 pages | ID: G488D674452FEN
LP Information

Abstracts

The global Biologic Therapeutics Drugs market size is predicted to grow from US$ 373220 million in 2025 to US$ 536500 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the ?Biologic Therapeutics Drugs Industry Forecast? looks at past sales and reviews total world Biologic Therapeutics Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Biologic Therapeutics Drugs sales for 2025 through 2031. With Biologic Therapeutics Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologic Therapeutics Drugs industry.

This Insight Report provides a comprehensive analysis of the global Biologic Therapeutics Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologic Therapeutics Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Biologic Therapeutics Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologic Therapeutics Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologic Therapeutics Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Therapeutics Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Avian Cell Culture
• Yeast
• Bacteria
• Insects Cell Culture
• Transgenics

Segmentation by Application:

• Rheumatoid Arthritis
• Anemia
• Cancer
• Diabetes
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pfizer
• AstraZeneca
• Novartis
• Merck
• Smith Medical
• GlaxoSmithKline
• Concord Biotech
• Aurobindo Pharma
• H. Lundbeck
• Retractable Technologies

Key Questions Addressed in this Report

What is the 10-year outlook for the global Biologic Therapeutics Drugs market?
What factors are driving Biologic Therapeutics Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biologic Therapeutics Drugs market opportunities vary by end market size?
How does Biologic Therapeutics Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Biologic Therapeutics Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Biologic Therapeutics Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Biologic Therapeutics Drugs by Country/Region, 2020, 2024 & 2031
2.2 Biologic Therapeutics Drugs Segment by Type
  2.2.1 Avian Cell Culture
  2.2.2 Yeast
  2.2.3 Bacteria
  2.2.4 Insects Cell Culture
  2.2.5 Transgenics
2.3 Biologic Therapeutics Drugs Sales by Type
  2.3.1 Global Biologic Therapeutics Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Biologic Therapeutics Drugs Sale Price by Type (2020-2025)
2.4 Biologic Therapeutics Drugs Segment by Application
  2.4.1 Rheumatoid Arthritis
  2.4.2 Anemia
  2.4.3 Cancer
  2.4.4 Diabetes
  2.4.5 Others
2.5 Biologic Therapeutics Drugs Sales by Application
  2.5.1 Global Biologic Therapeutics Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Biologic Therapeutics Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Biologic Therapeutics Drugs Breakdown Data by Company
  3.1.1 Global Biologic Therapeutics Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Biologic Therapeutics Drugs Sales Market Share by Company (2020-2025)
3.2 Global Biologic Therapeutics Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Biologic Therapeutics Drugs Revenue by Company (2020-2025)
  3.2.2 Global Biologic Therapeutics Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Biologic Therapeutics Drugs Sale Price by Company
3.4 Key Manufacturers Biologic Therapeutics Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Biologic Therapeutics Drugs Product Location Distribution
  3.4.2 Players Biologic Therapeutics Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BIOLOGIC THERAPEUTICS DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Biologic Therapeutics Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Biologic Therapeutics Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Biologic Therapeutics Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Biologic Therapeutics Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Biologic Therapeutics Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Biologic Therapeutics Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biologic Therapeutics Drugs Sales Growth
4.4 APAC Biologic Therapeutics Drugs Sales Growth
4.5 Europe Biologic Therapeutics Drugs Sales Growth
4.6 Middle East & Africa Biologic Therapeutics Drugs Sales Growth

5 AMERICAS

5.1 Americas Biologic Therapeutics Drugs Sales by Country
  5.1.1 Americas Biologic Therapeutics Drugs Sales by Country (2020-2025)
  5.1.2 Americas Biologic Therapeutics Drugs Revenue by Country (2020-2025)
5.2 Americas Biologic Therapeutics Drugs Sales by Type (2020-2025)
5.3 Americas Biologic Therapeutics Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Biologic Therapeutics Drugs Sales by Region
  6.1.1 APAC Biologic Therapeutics Drugs Sales by Region (2020-2025)
  6.1.2 APAC Biologic Therapeutics Drugs Revenue by Region (2020-2025)
6.2 APAC Biologic Therapeutics Drugs Sales by Type (2020-2025)
6.3 APAC Biologic Therapeutics Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Biologic Therapeutics Drugs by Country
  7.1.1 Europe Biologic Therapeutics Drugs Sales by Country (2020-2025)
  7.1.2 Europe Biologic Therapeutics Drugs Revenue by Country (2020-2025)
7.2 Europe Biologic Therapeutics Drugs Sales by Type (2020-2025)
7.3 Europe Biologic Therapeutics Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Biologic Therapeutics Drugs by Country
  8.1.1 Middle East & Africa Biologic Therapeutics Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Biologic Therapeutics Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Biologic Therapeutics Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Biologic Therapeutics Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biologic Therapeutics Drugs
10.3 Manufacturing Process Analysis of Biologic Therapeutics Drugs
10.4 Industry Chain Structure of Biologic Therapeutics Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Biologic Therapeutics Drugs Distributors
11.3 Biologic Therapeutics Drugs Customer

12 WORLD FORECAST REVIEW FOR BIOLOGIC THERAPEUTICS DRUGS BY GEOGRAPHIC REGION

12.1 Global Biologic Therapeutics Drugs Market Size Forecast by Region
  12.1.1 Global Biologic Therapeutics Drugs Forecast by Region (2026-2031)
  12.1.2 Global Biologic Therapeutics Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Biologic Therapeutics Drugs Forecast by Type (2026-2031)
12.7 Global Biologic Therapeutics Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Biologic Therapeutics Drugs Product Portfolios and Specifications
  13.1.3 Pfizer Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 AstraZeneca
  13.2.1 AstraZeneca Company Information
  13.2.2 AstraZeneca Biologic Therapeutics Drugs Product Portfolios and Specifications
  13.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 AstraZeneca Main Business Overview
  13.2.5 AstraZeneca Latest Developments
13.3 Novartis
  13.3.1 Novartis Company Information
  13.3.2 Novartis Biologic Therapeutics Drugs Product Portfolios and Specifications
  13.3.3 Novartis Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Novartis Main Business Overview
  13.3.5 Novartis Latest Developments
13.4 Merck
  13.4.1 Merck Company Information
  13.4.2 Merck Biologic Therapeutics Drugs Product Portfolios and Specifications
  13.4.3 Merck Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Merck Main Business Overview
  13.4.5 Merck Latest Developments
13.5 Smith Medical
  13.5.1 Smith Medical Company Information
  13.5.2 Smith Medical Biologic Therapeutics Drugs Product Portfolios and Specifications
  13.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Smith Medical Main Business Overview
  13.5.5 Smith Medical Latest Developments
13.6 GlaxoSmithKline
  13.6.1 GlaxoSmithKline Company Information
  13.6.2 GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolios and Specifications
  13.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 GlaxoSmithKline Main Business Overview
  13.6.5 GlaxoSmithKline Latest Developments
13.7 Concord Biotech
  13.7.1 Concord Biotech Company Information
  13.7.2 Concord Biotech Biologic Therapeutics Drugs Product Portfolios and Specifications
  13.7.3 Concord Biotech Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Concord Biotech Main Business Overview
  13.7.5 Concord Biotech Latest Developments
13.8 Aurobindo Pharma
  13.8.1 Aurobindo Pharma Company Information
  13.8.2 Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolios and Specifications
  13.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Aurobindo Pharma Main Business Overview
  13.8.5 Aurobindo Pharma Latest Developments
13.9 H. Lundbeck
  13.9.1 H. Lundbeck Company Information
  13.9.2 H. Lundbeck Biologic Therapeutics Drugs Product Portfolios and Specifications
  13.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 H. Lundbeck Main Business Overview
  13.9.5 H. Lundbeck Latest Developments
13.10 Retractable Technologies
  13.10.1 Retractable Technologies Company Information
  13.10.2 Retractable Technologies Biologic Therapeutics Drugs Product Portfolios and Specifications
  13.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Retractable Technologies Main Business Overview
  13.10.5 Retractable Technologies Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Biologic Therapeutics Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Biologic Therapeutics Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Avian Cell Culture
Table 4. Major Players of Yeast
Table 5. Major Players of Bacteria
Table 6. Major Players of Insects Cell Culture
Table 7. Major Players of Transgenics
Table 8. Global Biologic Therapeutics Drugs Sales by Type (2020-2025) & (Units)
Table 9. Global Biologic Therapeutics Drugs Sales Market Share by Type (2020-2025)
Table 10. Global Biologic Therapeutics Drugs Revenue by Type (2020-2025) & ($ million)
Table 11. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2020-2025)
Table 12. Global Biologic Therapeutics Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 13. Global Biologic Therapeutics Drugs Sale by Application (2020-2025) & (Units)
Table 14. Global Biologic Therapeutics Drugs Sale Market Share by Application (2020-2025)
Table 15. Global Biologic Therapeutics Drugs Revenue by Application (2020-2025) & ($ million)
Table 16. Global Biologic Therapeutics Drugs Revenue Market Share by Application (2020-2025)
Table 17. Global Biologic Therapeutics Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. Global Biologic Therapeutics Drugs Sales by Company (2020-2025) & (Units)
Table 19. Global Biologic Therapeutics Drugs Sales Market Share by Company (2020-2025)
Table 20. Global Biologic Therapeutics Drugs Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Biologic Therapeutics Drugs Revenue Market Share by Company (2020-2025)
Table 22. Global Biologic Therapeutics Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Biologic Therapeutics Drugs Producing Area Distribution and Sales Area
Table 24. Players Biologic Therapeutics Drugs Products Offered
Table 25. Biologic Therapeutics Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Biologic Therapeutics Drugs Sales by Geographic Region (2020-2025) & (Units)
Table 29. Global Biologic Therapeutics Drugs Sales Market Share Geographic Region (2020-2025)
Table 30. Global Biologic Therapeutics Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Biologic Therapeutics Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Biologic Therapeutics Drugs Sales by Country/Region (2020-2025) & (Units)
Table 33. Global Biologic Therapeutics Drugs Sales Market Share by Country/Region (2020-2025)
Table 34. Global Biologic Therapeutics Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Biologic Therapeutics Drugs Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Biologic Therapeutics Drugs Sales by Country (2020-2025) & (Units)
Table 37. Americas Biologic Therapeutics Drugs Sales Market Share by Country (2020-2025)
Table 38. Americas Biologic Therapeutics Drugs Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Biologic Therapeutics Drugs Sales by Type (2020-2025) & (Units)
Table 40. Americas Biologic Therapeutics Drugs Sales by Application (2020-2025) & (Units)
Table 41. APAC Biologic Therapeutics Drugs Sales by Region (2020-2025) & (Units)
Table 42. APAC Biologic Therapeutics Drugs Sales Market Share by Region (2020-2025)
Table 43. APAC Biologic Therapeutics Drugs Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Biologic Therapeutics Drugs Sales by Type (2020-2025) & (Units)
Table 45. APAC Biologic Therapeutics Drugs Sales by Application (2020-2025) & (Units)
Table 46. Europe Biologic Therapeutics Drugs Sales by Country (2020-2025) & (Units)
Table 47. Europe Biologic Therapeutics Drugs Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Biologic Therapeutics Drugs Sales by Type (2020-2025) & (Units)
Table 49. Europe Biologic Therapeutics Drugs Sales by Application (2020-2025) & (Units)
Table 50. Middle East & Africa Biologic Therapeutics Drugs Sales by Country (2020-2025) & (Units)
Table 51. Middle East & Africa Biologic Therapeutics Drugs Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Biologic Therapeutics Drugs Sales by Type (2020-2025) & (Units)
Table 53. Middle East & Africa Biologic Therapeutics Drugs Sales by Application (2020-2025) & (Units)
Table 54. Key Market Drivers & Growth Opportunities of Biologic Therapeutics Drugs
Table 55. Key Market Challenges & Risks of Biologic Therapeutics Drugs
Table 56. Key Industry Trends of Biologic Therapeutics Drugs
Table 57. Biologic Therapeutics Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Biologic Therapeutics Drugs Distributors List
Table 60. Biologic Therapeutics Drugs Customer List
Table 61. Global Biologic Therapeutics Drugs Sales Forecast by Region (2026-2031) & (Units)
Table 62. Global Biologic Therapeutics Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Biologic Therapeutics Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 64. Americas Biologic Therapeutics Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Biologic Therapeutics Drugs Sales Forecast by Region (2026-2031) & (Units)
Table 66. APAC Biologic Therapeutics Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Biologic Therapeutics Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 68. Europe Biologic Therapeutics Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Biologic Therapeutics Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 70. Middle East & Africa Biologic Therapeutics Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Biologic Therapeutics Drugs Sales Forecast by Type (2026-2031) & (Units)
Table 72. Global Biologic Therapeutics Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Biologic Therapeutics Drugs Sales Forecast by Application (2026-2031) & (Units)
Table 74. Global Biologic Therapeutics Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Pfizer Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Pfizer Biologic Therapeutics Drugs Product Portfolios and Specifications
Table 77. Pfizer Biologic Therapeutics Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. AstraZeneca Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. AstraZeneca Biologic Therapeutics Drugs Product Portfolios and Specifications
Table 82. AstraZeneca Biologic Therapeutics Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Latest Developments
Table 85. Novartis Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Novartis Biologic Therapeutics Drugs Product Portfolios and Specifications
Table 87. Novartis Biologic Therapeutics Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Main Business
Table 89. Novartis Latest Developments
Table 90. Merck Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Biologic Therapeutics Drugs Product Portfolios and Specifications
Table 92. Merck Biologic Therapeutics Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Smith Medical Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Smith Medical Biologic Therapeutics Drugs Product Portfolios and Specifications
Table 97. Smith Medical Biologic Therapeutics Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Smith Medical Main Business
Table 99. Smith Medical Latest Developments
Table 100. GlaxoSmithKline Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolios and Specifications
Table 102. GlaxoSmithKline Biologic Therapeutics Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. GlaxoSmithKline Main Business
Table 104. GlaxoSmithKline Latest Developments
Table 105. Concord Biotech Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Concord Biotech Biologic Therapeutics Drugs Product Portfolios and Specifications
Table 107. Concord Biotech Biologic Therapeutics Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Concord Biotech Main Business
Table 109. Concord Biotech Latest Developments
Table 110. Aurobindo Pharma Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolios and Specifications
Table 112. Aurobindo Pharma Biologic Therapeutics Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Aurobindo Pharma Main Business
Table 114. Aurobindo Pharma Latest Developments
Table 115. H. Lundbeck Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. H. Lundbeck Biologic Therapeutics Drugs Product Portfolios and Specifications
Table 117. H. Lundbeck Biologic Therapeutics Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. H. Lundbeck Main Business
Table 119. H. Lundbeck Latest Developments
Table 120. Retractable Technologies Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Retractable Technologies Biologic Therapeutics Drugs Product Portfolios and Specifications
Table 122. Retractable Technologies Biologic Therapeutics Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Retractable Technologies Main Business
Table 124. Retractable Technologies Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Biologic Therapeutics Drugs
Figure 2. Biologic Therapeutics Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologic Therapeutics Drugs Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Biologic Therapeutics Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Biologic Therapeutics Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Biologic Therapeutics Drugs Sales Market Share by Country/Region (2024)
Figure 10. Biologic Therapeutics Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Avian Cell Culture
Figure 12. Product Picture of Yeast
Figure 13. Product Picture of Bacteria
Figure 14. Product Picture of Insects Cell Culture
Figure 15. Product Picture of Transgenics
Figure 16. Global Biologic Therapeutics Drugs Sales Market Share by Type in 2025
Figure 17. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2020-2025)
Figure 18. Biologic Therapeutics Drugs Consumed in Rheumatoid Arthritis
Figure 19. Global Biologic Therapeutics Drugs Market: Rheumatoid Arthritis (2020-2025) & (Units)
Figure 20. Biologic Therapeutics Drugs Consumed in Anemia
Figure 21. Global Biologic Therapeutics Drugs Market: Anemia (2020-2025) & (Units)
Figure 22. Biologic Therapeutics Drugs Consumed in Cancer
Figure 23. Global Biologic Therapeutics Drugs Market: Cancer (2020-2025) & (Units)
Figure 24. Biologic Therapeutics Drugs Consumed in Diabetes
Figure 25. Global Biologic Therapeutics Drugs Market: Diabetes (2020-2025) & (Units)
Figure 26. Biologic Therapeutics Drugs Consumed in Others
Figure 27. Global Biologic Therapeutics Drugs Market: Others (2020-2025) & (Units)
Figure 28. Global Biologic Therapeutics Drugs Sale Market Share by Application (2024)
Figure 29. Global Biologic Therapeutics Drugs Revenue Market Share by Application in 2025
Figure 30. Biologic Therapeutics Drugs Sales by Company in 2025 (Units)
Figure 31. Global Biologic Therapeutics Drugs Sales Market Share by Company in 2025
Figure 32. Biologic Therapeutics Drugs Revenue by Company in 2025 ($ millions)
Figure 33. Global Biologic Therapeutics Drugs Revenue Market Share by Company in 2025
Figure 34. Global Biologic Therapeutics Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Biologic Therapeutics Drugs Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Biologic Therapeutics Drugs Sales 2020-2025 (Units)
Figure 37. Americas Biologic Therapeutics Drugs Revenue 2020-2025 ($ millions)
Figure 38. APAC Biologic Therapeutics Drugs Sales 2020-2025 (Units)
Figure 39. APAC Biologic Therapeutics Drugs Revenue 2020-2025 ($ millions)
Figure 40. Europe Biologic Therapeutics Drugs Sales 2020-2025 (Units)
Figure 41. Europe Biologic Therapeutics Drugs Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Biologic Therapeutics Drugs Sales 2020-2025 (Units)
Figure 43. Middle East & Africa Biologic Therapeutics Drugs Revenue 2020-2025 ($ millions)
Figure 44. Americas Biologic Therapeutics Drugs Sales Market Share by Country in 2025
Figure 45. Americas Biologic Therapeutics Drugs Revenue Market Share by Country (2020-2025)
Figure 46. Americas Biologic Therapeutics Drugs Sales Market Share by Type (2020-2025)
Figure 47. Americas Biologic Therapeutics Drugs Sales Market Share by Application (2020-2025)
Figure 48. United States Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Biologic Therapeutics Drugs Sales Market Share by Region in 2025
Figure 53. APAC Biologic Therapeutics Drugs Revenue Market Share by Region (2020-2025)
Figure 54. APAC Biologic Therapeutics Drugs Sales Market Share by Type (2020-2025)
Figure 55. APAC Biologic Therapeutics Drugs Sales Market Share by Application (2020-2025)
Figure 56. China Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60. India Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Biologic Therapeutics Drugs Sales Market Share by Country in 2025
Figure 64. Europe Biologic Therapeutics Drugs Revenue Market Share by Country (2020-2025)
Figure 65. Europe Biologic Therapeutics Drugs Sales Market Share by Type (2020-2025)
Figure 66. Europe Biologic Therapeutics Drugs Sales Market Share by Application (2020-2025)
Figure 67. Germany Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. France Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Biologic Therapeutics Drugs Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Biologic Therapeutics Drugs Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Biologic Therapeutics Drugs Sales Market Share by Application (2020-2025)
Figure 75. Egypt Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Biologic Therapeutics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Biologic Therapeutics Drugs in 2025
Figure 81. Manufacturing Process Analysis of Biologic Therapeutics Drugs
Figure 82. Industry Chain Structure of Biologic Therapeutics Drugs
Figure 83. Channels of Distribution
Figure 84. Global Biologic Therapeutics Drugs Sales Market Forecast by Region (2026-2031)
Figure 85. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Application (2026-2031)